GRTS
Gritstone Bio Inc

6,355
Mkt Cap
$118.00
Volume
97.00
52W High
$1.05
52W Low
$0.00
PE Ratio
0.00
GRTS Fundamentals
Price
$0.00
50D MA
$0.00
Beta
-51.65
Avg. Volume
55,455.14
P/B
0.00
Loading...
Loading...
Gritstone bio, Inc. clinical-stage biotechnology company, which engages in developing the next generation of cancer immunotherapies to fight multiple cancer types. The company was founded by Andrew Allen, Timothy Chan, Mark Cobbold, Graham Lord, Naiyer Rizvi and Jean-Charles Soria in August 2015 and is headquartered in Emeryville, CA.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
N/A

Frequently Asked Questions

What is Market Cap of Gritstone Bio Inc?
What is the 52-week high for Gritstone Bio Inc?
What is the 52-week low for Gritstone Bio Inc?
What is the PE ratio of Gritstone Bio Inc?
What is the Price-to-Book ratio of Gritstone Bio Inc?
What is the 50-day moving average of Gritstone Bio Inc?

Latest GRTS News

View
No GRTS news at the moment.

Advertisement|Remove ads.

Advertisement|Remove ads.